Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9481 Triple Negative Breast Neoplasms 635 Neoplasms 413 Lung Neoplasms 342 Prostatic Neoplasms 321 Ovarian Neoplasms 299 Colorectal Neoplasms 289 Neoplasm Metastasis 280 Motor Activity 267 Carcinoma, Intraductal, Noninfiltrating 231 Colonic Neoplasms 193 Breast Neoplasms, Male 172 Lymphedema 170 Melanoma 158 Pancreatic Neoplasms 152 Breast Carcinoma In Situ 151 Carcinoma, Non-Small-Cell Lung 149 Uterine Cervical Neoplasms 144 Fatigue 140 Head and Neck Neoplasms 132 Pain 122 Breast Cancer Female 122 Brain Neoplasms 118 Stomach Neoplasms 117 Sarcoma 106 Depression 105 Breast Cancer Lymphedema 101 Anxiety Disorders 101 Lymphoma 96 Cardiotoxicity 89

Interventions

Trastuzumab 1 Paclitaxel 1 Epirubicin 1 Cyclophosphamide 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Unilateral HER2 Positive Breast Cancer × Breast × Clear all

NCT01594177 2014-03-13

DAFNE

GBG Forschungs GmbH

Phase 2 Completed

Unilateral HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡